Bioceres Crop Solutions Corp.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $20.8M
- Price
- $0.3262
- % Change (Daily % change from the live per-ticker quote feed.)
- -4.14%
- Volume
- 73.1K
About
Bioceres Crop Solutions Corp. (BIOX) is a company dedicated to enhancing agricultural output through a diverse range of solutions. Its operations are organized into three principal divisions. The Seed and Integrated Products segment is responsible for creating and bringing to market cutting-edge seed technologies, genetic material, biotechnological innovations, and specialized seed coatings. Under its Crop Protection segment, the company formulates, manufactures, and distributes a comprehensive array of products, including Rizoderma, various adjuvants, therapeutic agents, weed killers, insect eradicators, fungal treatments, and pest lures. The Crop Nutrition unit focuses on the development, production, and distribution of inoculants, bio-stimulants, and both organic and micro-granular fertilizers. A notable offering from Bioceres is HB4, an innovative seed technology engineered for drought resistance. The enterprise maintains a significant presence across several countries, including Argentina, Uruguay, France, and South Africa, alongside broader international operations. Established in 2001, the firm's main offices are situated in Rosario, Argentina. Bioceres Crop Solutions Corp. functions as a subsidiary entity under the umbrella of Bioceres LLC.
Quick stats
Shares outstanding63.8M
Computed float59.3M
Float / shares92.9%
Key info
SectorBasic Materials
IndustryAgricultural Inputs
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001769484
AI Summary
AI-generated1/12
majormixedearnings
Bioceres Crop Solutions Reports Fiscal Fourth Quarter and Full-Year 2026 Financial and Operating Results
Bioceres closed fiscal 2026 with revenue from continuing operations of $238.3 million, down 18% year over year, with roughly half the decline tied to the substantially completed reconfiguration of its Seeds business and reduced HB4-related activity.
Fourth-quarter operations inflected: revenue was broadly stable at $55.9 million, the net loss from continuing operations narrowed to $31.8 million from $54.4 million, and Adjusted EBITDA swung to positive $0.6 million on cost actions that cut FY26 SG&A by 24%.
The balance sheet is the pressure point — the January foreclosure auction of Pro Farm Group produced a $179.4 million loss from discontinued operations, equity attributable to owners fell to $39.1 million from $265.4 million, and cash ended at $11.2 million against $118.6 million of current secured notes.
Management is actively addressing the capital structure and liquidity position, while litigation with certain creditors over the disputed note acceleration and foreclosure remains unresolved.
Red flags
- FY26 loss from discontinued operations of $179.4 million following the January 2026 foreclosure auction of Pro Farm Group
- Cash of $11.2 million versus $118.6 million of current secured notes and $47.3 million of current borrowings — acute liquidity stress
- Equity attributable to owners collapsed to $39.1 million from $265.4 million a year earlier
- Ongoing litigation with creditors; company disputes the note acceleration and foreclosure process
- FY26 financial result of -$50.9 million consumed roughly two-thirds of gross profit — heavy debt-service burden
- FY26 revenue down 18% and net loss from continuing operations widened to $54.4 million from $49.1 million
- $4.0 million non-recurring inventory obsolescence charge masked 4Q gross profit performance